Published in CMAJ on October 30, 2001
Oral Vitamin K for Warfarin Associated Coagulopathy | NCT00143715
The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 3.24
Determination of the clinical importance of study results. J Gen Intern Med (2002) 1.34
Effectiveness of a parent "buddy" program for mothers of very preterm infants in a neonatal intensive care unit. CMAJ (2003) 1.16
Delta inflation: a bias in the design of randomized controlled trials in critical care medicine. Crit Care (2010) 1.09
A systematic review of the quality of publications reporting coronary artery bypass grafting trials. Can J Surg (2007) 0.92
Classification and prevalence of spin in abstracts of non-randomized studies evaluating an intervention. BMC Med Res Methodol (2015) 0.91
Sonographic assessment of normal kidney dimensions in the first year of life--a study of 992 healthy infants. Pediatr Nephrol (2007) 0.87
Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products. BMC Complement Altern Med (2009) 0.83
Interpretation of Results of Studies Evaluating an Intervention Highlighted in Google Health News: A Cross-Sectional Study of News. PLoS One (2015) 0.82
Cross-sectional analysis of the reporting of continuous outcome measures and clinical significance of results in randomized trials of non-pharmacological interventions. Trials (2014) 0.82
Reporting the clinical importance of randomized controlled trials. CMAJ (2002) 0.75
Reporting the clinical importance of randomized controlled trials. CMAJ (2002) 0.75
Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials (1989) 15.99
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med (2001) 11.48
Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA (1999) 9.46
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
The Newcastle exercise project: a randomised controlled trial of methods to promote physical activity in primary care. BMJ (1999) 8.16
Statistical power, sample size, and their reporting in randomized controlled trials. JAMA (1994) 6.36
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA (1999) 5.29
Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet (1999) 5.15
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med (1999) 4.45
Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet (1999) 4.27
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med (1998) 3.86
Cognitive effects after epidural vs general anesthesia in older adults. A randomized trial. JAMA (1995) 3.22
A comparison of standard cardiopulmonary resuscitation and active compression-decompression resuscitation for out-of-hospital cardiac arrest. French Active Compression-Decompression Cardiopulmonary Resuscitation Study Group. N Engl J Med (1999) 2.79
A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. N Engl J Med (1999) 2.70
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ (1999) 2.44
Claims of equivalence in medical research: are they supported by the evidence? Ann Intern Med (2000) 2.27
Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ (1999) 2.21
Lorazepam for the prevention of recurrent seizures related to alcohol. N Engl J Med (1999) 2.17
Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax (2000) 2.06
Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med (1999) 1.85
Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1999) 1.63
Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial. Ann Intern Med (1999) 1.61
The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1999) 1.58
Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. The ICAI Study Group. Ischemia Cronica degli Arti Inferiori. Ann Intern Med (1999) 1.54
Randomised controlled trial of effect of Baby Check on use of health services in first 6 months of life. BMJ (1999) 1.51
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol (2000) 1.49
Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration. Dement Geriatr Cogn Disord (2000) 0.97
Antithrombotic and thrombolytic therapy for ischemic stroke. Chest (1998) 0.86
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
The Canadian CT Head Rule for patients with minor head injury. Lancet (2001) 7.91
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83
The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA (2001) 7.48
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol (1991) 6.55
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA (1999) 4.31
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med (1993) 3.67
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science (1984) 3.47
Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2007) 3.28
The Ottawa patient decision aids. Eff Clin Pract (1999) 3.22
Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials (1999) 2.99
Evidence-based medicine and the practicing clinician. J Gen Intern Med (1999) 2.99
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81
Variation in emergency department use of cervical spine radiography for alert, stable trauma patients. CMAJ (1997) 2.79
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ (1995) 2.50
Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg (1998) 2.44
The rational clinical examination. Does this patient have a clinically important carotid bruit? JAMA (1993) 2.38
Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28
What is the quality of life for survivors of cardiac arrest? A prospective study. Acad Emerg Med (1999) 2.27
Initiating, conducting and maintaining guidelines development programs. CMAJ (1993) 2.24
Antithrombotic therapy in atrial fibrillation. Chest (1992) 2.21
A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1999) 2.19
Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18
Antithrombotic therapy in atrial fibrillation. Chest (1995) 2.08
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med (1999) 2.07
The hierarchy of functional loss associated with cognitive decline in older persons. J Gerontol A Biol Sci Med Sci (2001) 1.89
Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82
Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med (1998) 1.68
Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites. Br J Clin Pharmacol (1984) 1.66
The Canadian CT Head Rule Study for patients with minor head injury: rationale, objectives, and methodology for phase I (derivation). Ann Emerg Med (2001) 1.65
Assessing the quality of newspaper medical advice columns for elderly readers. CMAJ (1999) 1.54
Evaluation of a decision aid for patients considering autologous blood donation before open-heart surgery. CMAJ (2001) 1.54
When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ (2000) 1.51
Cyclosporin prevents diabetes in BB Wistar rats. Lancet (1983) 1.50
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol (2000) 1.49
Asymptomatic Wolff-Parkinson-White. Should we intervene? Circulation (1989) 1.47
Autologous versus allogeneic transfusion: patients' perceptions and experiences. CMAJ (1999) 1.45
An economic analysis of the Ottawa knee rule. Ann Emerg Med (1999) 1.43
Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators. N Engl J Med (1994) 1.43
Randomised study of n of 1 trials versus standard practice. BMJ (1996) 1.41
A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg (1999) 1.40
Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay. Clin Chem (1983) 1.38
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2001) 1.37
Variation in ED use of computed tomography for patients with minor head injury. Ann Emerg Med (1997) 1.29
Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy. J Gen Intern Med (2000) 1.23
Cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1996) 1.21
Awareness and use of the Ottawa ankle and knee rules in 5 countries: can publication alone be enough to change practice? Ann Emerg Med (2001) 1.19
Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg (1998) 1.17
Effectiveness of emergency medical services for victims of out-of-hospital cardiac arrest: a metaanalysis. Ann Emerg Med (1996) 1.15
Cost-effectiveness analysis of the Ottawa Ankle Rules. Ann Emerg Med (1995) 1.13
Cyclosporine for treatment of early type I diabetes: preliminary results. N Engl J Med (1983) 1.10
A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost-effectiveness and its impact on health-related quality of life. Clin Orthop Relat Res (1994) 1.10
Patient preference-based treatment thresholds and recommendations: a comparison of decision-analytic modeling with the probability-tradeoff technique. Med Decis Making (2001) 1.10
A policy analysis of major decisions relating to Creutzfeldt-Jakob disease and the blood supply. CMAJ (2001) 1.10
Cyclosporin A: a powerful immunosuppressant. Can Med Assoc J (1982) 1.09
Surveying physicians to determine the minimal important difference: implications for sample-size calculation. J Clin Epidemiol (1999) 1.06
Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant (2004) 1.05
Emergency physicians' attitudes toward and use of clinical decision rules for radiography. Acad Emerg Med (1998) 1.05
A survey of clinician attitudes and management practices in hypertension. J Hum Hypertens (1997) 1.04
Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest (1999) 1.04
Utilization of technologies to reduce allogeneic blood transfusion in the United States. Transfus Med (2001) 1.01
Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators. Int J Technol Assess Health Care (1999) 1.00
Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. Acad Emerg Med (1995) 0.98
Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration. Dement Geriatr Cogn Disord (2000) 0.97
Feasibility, limits and problems of clinical studies in Intensive Care Unit. Minerva Anestesiol (2007) 0.96
Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature. Transfus Med Rev (1998) 0.96
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart (2002) 0.95
Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2004) 0.95
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2000) 0.95
Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group. CMAJ (1996) 0.94
Economic evaluations of technologies to minimize perioperative transfusion: a systematic review of published studies. International Study of Peri-operative Transfusion (ISPOT) investigators. Transfus Med Rev (1999) 0.90
Economic analysis of erythropoietin use in orthopaedic surgery. Transfus Med (1999) 0.90
Canadian CT head rule study for patients with minor head injury: methodology for phase II (validation and economic analysis). Ann Emerg Med (2001) 0.90
Interaction between phenytoin and cyclosporine following organ transplantation. Transplantation (1984) 0.89
HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study. Am J Transplant (2014) 0.89
Towards a better yardstick: the choice of treatment thresholds in hypertension. Can J Cardiol (1998) 0.88
The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada. Soc Sci Med (1992) 0.88
Platelet-rich plasmapheresis in cardiac surgery: a meta-analysis of the effect on transfusion requirements. J Thorac Cardiovasc Surg (1998) 0.88
The Nicolas Andry award: comparative results of cemented and cementless total hip arthroplasty. Clin Orthop Relat Res (1996) 0.87
The Ontario trial of active compression-decompression cardiopulmonary resuscitation for in-hospital and prehospital cardiac arrest. JAMA (1996) 0.87
Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument. Bone Marrow Transplant (2002) 0.87
Subcortical vascular dementia: survey of treatment patterns and research considerations. Can J Neurol Sci (1998) 0.86
A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group. Transplant Proc (1991) 0.86
Cyclosporine: action, pharmacokinetics, and effect in the BB rat model. Metabolism (1983) 0.86
What should be included in meta-analyses? An exploration of methodological issues using the ISPOT meta-analyses. Int J Technol Assess Health Care (2000) 0.84
Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group). Nephrol Dial Transplant (1992) 0.83
How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey. Cancer Prev Control (1998) 0.82
A randomized clinical trial comparing cemented to cementless total hip replacement in 250 osteoarthritic patients: the impact on health related quality of life and cost effectiveness. Iowa Orthop J (1994) 0.81
Use of vascular risk-modifying medications for diabetic patients differs between physician specialties. Diabet Med (2006) 0.81
Cyclosporin for pulmonary sarcoidosis. Lancet (1984) 0.80
Indications for computed tomography after minor head injury. Canadian CT Head and Cervical-Spine Study Group. N Engl J Med (2000) 0.80
Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. COPES Study Group. Lancet (1993) 0.80
The validity of survivorship analysis in total joint arthroplasty. J Bone Joint Surg Am (1989) 0.80
Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol (1983) 0.79